Medifocus-Inc-newLogo.png
Medifocus, Inc. Announces Global Market Expansion with Prolieve® Performed and Reimbursed by Insurance Carriers in Hong Kong
03 janv. 2019 09h15 HE | Medifocus Inc
COLUMBIA, Md. and TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Medifocus, Inc. (OTCQB: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products...
Medifocus-Inc-newLogo.png
Medifocus, Inc. Announces Recent Publication Highlighting Its Focal Therapy for Prostate and Breast Cancer Treatment Initiatives
27 déc. 2018 09h15 HE | Medifocus Inc
COLUMBIA, Md. and TORONTO, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Medifocus, Inc. (OTCQB: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products...
Medifocus-Inc-newLogo.png
Uptick Newswire’s Stock Day Podcast Hosts Medifocus, Inc.’s CEO to Discuss Their Minimally Invasive Breakthrough Treatments for Prostate and Breast Cancers
10 déc. 2018 08h30 HE | Medifocus Inc
PHOENIX, Dec. 10, 2018 (GLOBE NEWSWIRE) -- The Uptick Newswire Stock Day Podcast features Medifocus, Inc. (OTCQB: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a...
Medifocus-Inc-newLogo.png
Medifocus, Inc. Announces FDA PMA Supplement Approval for New Labeling Based on Successful Completion of FDA Post Approval Study (PAS) for the Prolieve® Thermodilatation™ Device
03 déc. 2018 09h10 HE | Medifocus Inc
COLUMBIA, Md. and TORONTO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Medifocus, Inc. (OTCQB: MDFZF and TSXV: MFS), a biotechnology company with a portfolio of medical technologies utilizing Focused...
Medifocus-Inc-newLogo.png
Medifocus Inc.’s General Manager and Medical Director Discuss Their Breakthrough Products with Uptick Newswire’s Stock Day Podcast
31 oct. 2018 08h30 HE | Medifocus Inc
PHOENIX, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Medifocus, Inc. (TSXV:MFS) (OTCQB: MDFZF) (“the Company”) is a Biotechnology Company with a portfolio of medical technologies that utilize patented Focal...